Seniors' health

FILE - In this Aug. 14, 2018 file photo, a doctor looks at a PET brain scan at the Banner Alzheimers Institute in Phoenix. Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because of rare gene flaws. The results announced Monday, Feb. 10, 2020, are another disappointment for the approach that scientists have focused on for many years -- trying to remove a harmful protein that builds up in the brains of people with the disease. (AP Photo/Matt York, File)
February 10, 2020 - 8:04 am
Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because they inherited rare gene flaws. The results announced Monday are another disappointment for the approach that scientists...
Read More
February 07, 2020 - 12:37 pm
AMSTERDAM (AP) — A Dutch organization that carries out euthanasia received 3,122 requests last year, a 22% increase from the year before, the Euthanasia Expertise Center said Friday. “Every work day, 13 people say: 'Help me, I can’t go on,'” Steven Pleiter, director of the center formerly known as...
Read More
Speaker of the House Nancy Pelosi, D-Calif., speaks during her weekly news conference on Capitol Hill, Thursday, Dec. 12, 2019, in Washington. (AP Photo/Jose Luis Magana)
December 12, 2019 - 3:22 pm
WASHINGTON (AP) — Sharpening their 2020 election message, House Democrats on Thursday pushed through legislation that would empower Medicare to negotiate prescription drug prices and offer new benefits for seniors. The vote along party lines was 230-192. Speaker Nancy Pelosi's bill would cap...
Read More
December 06, 2019 - 9:10 pm
WASHINGTON (AP) — A bipartisan Senate bill to curb prescription drug costs for Medicare recipients got a makeover Friday to lower copays and make it easier for seniors to budget for their expenses. The updated legislation unveiled by Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore., would lower...
Read More
This image from the Medicare.gov website shows the landing page to find a drug plan for seniors. Leading senators are urging Medicare to allow seniors concerned about their drug plan pick for next year to switch if they believe they received inaccurate information. (Medicare via AP)
December 06, 2019 - 3:43 pm
WASHINGTON (AP) — Leading senators are urging Medicare to allow seniors concerned about their drug plan pick for next year to switch if they received inaccurate information due to changes the agency made this sign-up season. The request from 14 Democrats and one Independent comes as open enrollment...
Read More
Charles Flagg, who is stricken with Alzheimer's disease, sits for an infusion while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)
December 05, 2019 - 3:43 pm
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval. Excitement and...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
December 04, 2019 - 8:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More
President Donald Trump delivers remarks on Medicare at the Sharon L. Morse Performing Arts Center, Thursday, Oct. 3, 2019, in The Villages, Fla. (AP Photo/Evan Vucci)
October 03, 2019 - 4:27 pm
THE VILLAGES, Fla. (AP) — President Donald Trump on Thursday accused Democrats of an all-out attempt to “totally obliterate Medicare” and portrayed himself as the program’s defender as he signed a directive to expand the program’s private insurance options. Trump skipped past his own proposals for...
Read More
In this Sept. 30, 2019, photo, a signboard says "Consumption tax hike, 8 percent to 10 percent", at a mass home electronics retailer in Tokyo. Japan has raised consumption tax to 10 percent from 8 percent, amid concerns that it could sink the Japanese economy though government officials say ample measures are taken to minimize the impact. (Shinji Kita/Kyodo News via AP)
October 01, 2019 - 4:14 am
TOKYO (AP) — Japan raised its national sales tax to 10% from 8% on Tuesday, risking short-term pain for the sake of the country's future financial stability as it copes with a fast aging and shrinking population. Previous tax increases, a 2-point increase to 5% in 1997 and another to 8% in 2014,...
Read More
Speaker of the House Nancy Pelosi, D-Calif., arrives for a closed-door meeting with the House Democratic Caucus, Wednesday, Sept. 18, 2019, at the Capitol in Washington. (AP Photo/J. Scott Applewhite)
September 19, 2019 - 4:05 pm
WASHINGTON (AP) — House Speaker Nancy Pelosi, trying to seize the agenda on a leading consumer issue, announced an ambitious prescription drug plan Thursday that would allow Medicare to negotiate prices for seniors and younger people. The proposal would direct Medicare to bargain over as many as...
Read More

Pages